UNSPSC 51294201: Bazinaprine

This classification denotes a monoamine oxidase inhibitor and antidepressant agent with the molecular formula C17H19N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NU8Y4C529J, chemically known as 4-pyridazinecarbonitrile, 3-((2-(4-morpholinyl)ethyl)amino)-6-phenyl- but generally known as bazinaprine, which bears US NIH Compound Identifier 72119. European Medicines Agency schedules Bazinaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05672MIG.

UNSPSC 51294201 Bazinaprine is a Commodity code that in practice covers pharmaceutical and medical countermeasure procurement by state and local health authorities. The recent solicitation activity under this code shows state and local governments buying naloxone and drug deactivation systems to support community health and emergency response initiatives, rather than bazinaprine specifically. Issuing bodies include county health departments and community health programs operating within county government structures. The work involves competitive procurement of pharmaceutical products and related systems through fixed-fee contracts, with vendors required to meet standard compliance requirements including drug-free workplace certification, E-Verify authorization, and insurance coverages for workers' compensation and general liability.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the county community health building in Sanford. The IFB response deadline was July 26, 2023, and the contract includes a two-year initial term with one-year renewal option and a three-month probationary period. This represents the primary recent state and local opportunity visible under the code; the geographic activity is concentrated in Florida based on available records.